Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting DNA methyltransferases in non-small-cell lung cancer
Minnatallah Al-Yozbaki, Ibtissam Jabre, Naeem H. Syed, et al.
Seminars in Cancer Biology (2021) Vol. 83, pp. 77-87
Closed Access | Times Cited: 25

Showing 25 citing articles:

Targeting epigenetic regulators to overcome drug resistance in cancers
Nan Wang, Ting Ma, Bin Yu
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 159
Small cell lung cancer transformation: From pathogenesis to treatment
Xiaomeng Yin, Yueyi Li, Hang Wang, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 595-606
Closed Access | Times Cited: 73
The Mechanism of DNA Methylation and miRNA in Breast Cancer
Lingyuan Ma, Chenyu Li, Hanlin Yin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9360-9360
Open Access | Times Cited: 37
Recent progress of biosensors for the detection of lung cancer markers
Shanchuan Chen, Minghan Li, Ting Weng, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 25, pp. 5715-5747
Closed Access | Times Cited: 22
Understanding the role of DNA methylation in colorectal cancer: Mechanisms, detection, and clinical significance
Ningning Zhao, Chuanxi Lai, Yunfei Wang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 3, pp. 189096-189096
Closed Access | Times Cited: 7
The dual effects of Benzo(a)pyrene/Benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide on DNA Methylation
Cheng Zhao, Huixin Jin, Lei Yu, et al.
The Science of The Total Environment (2024) Vol. 950, pp. 175042-175042
Closed Access | Times Cited: 4
Licorice extract inhibits growth of non-small cell lung cancer by down-regulating CDK4-Cyclin D1 complex and increasing CD8+ T cell infiltration
Jinglin Zhu, Ruifei Huang, Ruijie Yang, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 25
Targeting the epigenetic processes to enhance antitumor immunity in small cell lung cancer
Hao Luo, Jinlu Shan, Hong Zhang, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 960-970
Open Access | Times Cited: 17
HDAC inhibitor ITF2357 reduces resistance of mutant-KRAS non-small cell lung cancer to pemetrexed through a HDAC2/miR-130a-3p-dependent mechanism
Jian Cui, Fei Xu, Wei Bai, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 9
The role of DNA methylation and DNA methyltransferases (DNMTs) as potential biomarker and therapeutic target in non-small cell lung cancer (NSCLC)
Khairunnisa Mohd Kamal, Ahmad Rohi Ghazali, Nurul‐Syakima Ab Mutalib, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e38663-e38663
Open Access | Times Cited: 3
Multilevel Mechanisms of Cancer Drug Resistance
Małgorzata Roszkowska
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12402-12402
Open Access | Times Cited: 3
Advances in Targeted Therapy Against Driver Mutations and Epigenetic Alterations in Non-Small Cell Lung Cancer
Jiajian Shi, Yuchen Chen, Chentai Peng, et al.
ONCOLOGIE (2022) Vol. 24, Iss. 4, pp. 613-648
Open Access | Times Cited: 14
Reserpine, a novel N6-methyladenosine regulator, reverses Lenvatinib resistance in hepatocellular carcinoma
Lei Zhao, Heyao Ma, Yuhui Jiang, et al.
Phytomedicine (2024) Vol. 135, pp. 156002-156002
Closed Access | Times Cited: 2
Mass Spectrometry-Based Proteomics: Analyses Related to Drug-Resistance and Disease Biomarkers
Marco Agostini, Pietro Traldi, Mahmoud Hamdan
Medicina (2023) Vol. 59, Iss. 10, pp. 1722-1722
Open Access | Times Cited: 4
Premalignant Progression in the Lung: Knowledge Gaps and Novel Opportunities for Interception of Non-Small Cell Lung Cancer. An Official American Thoracic Society Research Statement
Seyed Javad Moghaddam, Society Document, Rajkumar Savai, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 210, Iss. 5, pp. 548-571
Open Access | Times Cited: 1
Methylation modification is a poor prognostic factor in non-small cell lung Cancer and regulates the tumor microenvironment: mRNA molecular structure and function
Kai Yang, Yuping Yang, Yu Lin, et al.
International Journal of Biological Macromolecules (2024) Vol. 282, pp. 137214-137214
Closed Access | Times Cited: 1
KCNJ15 inhibits chemical-induced lung carcinogenesis and progression through GNB1 mediated Hippo pathway
Hongqiang Chen, Na Wang, Yong Zeng, et al.
Toxicology (2024) Vol. 511, pp. 154034-154034
Closed Access | Times Cited: 1
Epigenetic upregulation of spleen tyrosine kinase in cancer cells through p53-dependent downregulation of DNA methyltransferase
Duen-Yi Huang, Shang-Te Lu, Yuan-Shen Chen, et al.
Experimental Cell Research (2023) Vol. 425, Iss. 2, pp. 113540-113540
Open Access | Times Cited: 3
Integrated Bioinformatic Analysis Identifies TIPIN as a Prognostic Biomarker in Hepatocellular Carcinoma
Hui Chen, Chun‐Ting Zhang, Qianmei Zhou, et al.
Disease Markers (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 5
The clinical significance and mechanism of microRNA-22-3p targeting TP53 in lung adenocarcinoma
Rui Lin, Guosheng Li, Xiang-Yu Gan, et al.
Technology and Health Care (2023) Vol. 31, Iss. 5, pp. 1691-1707
Closed Access | Times Cited: 2
A novel mTOR-associated gene signature for predicting prognosis and evaluating tumor immune microenvironment in lung adenocarcinoma
Zhi Zheng, Yanqi Li, Xiao Lu, et al.
Computers in Biology and Medicine (2022) Vol. 145, pp. 105394-105394
Open Access | Times Cited: 2
Special Issue: Epigenetic regulation of cancer progression: Promises and progress
Aamir Ahmad
Seminars in Cancer Biology (2021) Vol. 83, pp. 1-3
Closed Access | Times Cited: 2
Epigenetic therapy in lung cancer
Michael Conroy, Áine O’Connor, Maeve Bailey‐Whyte, et al.
Elsevier eBooks (2023), pp. 237-274
Closed Access
Identification of hub-methylated differentially expressed genes in lung adenocarcinoma and immunotherapy resistance
Xiaodie Ye, Weiguo Cai, Jian Zhang, et al.
Research Square (Research Square) (2022)
Open Access
Licorice Extracts Inhibits growth of Non-Small Cell Lung Cancer by Down-Regulating CDK4-Cyclin D1 Complex and Increasing CD8+ T Cell Infiltration
Ruifei Huang, Jinglin Zhu, Ruijie Yang, et al.
Research Square (Research Square) (2021)
Open Access
Page 1

Scroll to top